Cargando…
Dopamine agonist inhibits vascular endothelial growth factor protein production and secretion in granulosa cells
BACKGROUND: Dopamine receptor 2 agonists (D2-ags) inhibit vascular endothelial growth factor (VEGF) secretion in luteinized granulosa cells (LGCs) both in vitro and in vivo. However, the mechanism of D2 regulation of the VEGF/VEGF Receptor 2 (VEGFR-2) pathway remains to be elucidated. We sought to d...
Autores principales: | Ferrero, Hortensia, García-Pascual, Carmen M., Pellicer, Nuria, Simón, Carlos, Pellicer, Antonio, Gómez, Raúl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574352/ https://www.ncbi.nlm.nih.gov/pubmed/26377185 http://dx.doi.org/10.1186/s12958-015-0102-4 |
Ejemplares similares
-
Proteomic analysis of extracellular vesicles secreted by primary human epithelial endometrial cells reveals key proteins related to embryo implantation
por: Segura-Benítez, Marina, et al.
Publicado: (2022) -
The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial(†)
por: Busso, Cristiano, et al.
Publicado: (2010) -
Dopamine receptor repertoire of human granulosa cells
por: Rey-Ares, Veronica, et al.
Publicado: (2007) -
Prevalence of hypersexual behavior in Parkinson’s disease patients: Not restricted to males and dopamine agonist use
por: Cooper, Christine A, et al.
Publicado: (2009) -
Inflammatory nociception diminishes dopamine release and increases dopamine D2 receptor mRNA in the rat's insular cortex
por: Coffeen, Ulises, et al.
Publicado: (2010)